Large-scale testing (Phase 3)Study completedNCT03160885
What this trial is testing
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)
Who this might be right for
Atopic Dermatitis
LEO Pharma 794